Pioneers in the industry, we offer iversun ivermectin 12mg tablets, 200mg pirfenidone tablet, 40mg lomustine capsules, 50mg bicalutamide tablet, acyclovir 200mg acivir dt 200mg tab and 100mg arpimune me cyclosporine capsule from India.
₹ 100 / Strip of 10 Tablets Get Latest Price
| Strength | 12 mg |
| Usage | Human |
| Packaging Size | 10x10 Tablet |
| Brand | iversun |
| Dosage Form | Tablet |
| Prescription | Non Prescription |
| Treatment | Worm Infestation |
| Packaging Type | Strip |
| Shelf Life | 24 Month |
Iversun 12mg Tablet DT is best taken on an empty stomach. You usually need to take it only once to get rid of your infection. Take it exactly as directed by your doctor, and avoid skipping doses. Proper adherence ensures the complete elimination of parasites, prevents reinfection, and reduces the risk of treatment failure. However, if there is no improvement after taking it, consult a doctor.
₹ 380 / Packet Get Latest Price
| Strength | 200 mg |
| Packaging Type | Box |
| Brand | Pirfeheal |
| Manufactured By | Healing Pharma |
| Composition | Pirfenidone |
| Shelf Life | 24 Months |
| Type Of Medicines | Allopathic |
| Pack Size | 3 x 10 Tablets |
| Treatment | Treatment Of Idiopathic Pulmonary Fibrosis |
₹ 1600 / Box Get Latest Price
| Strength | 40 mg |
| Prescription/Non prescription | Prescription |
| Brand | Belustine |
| Composition | Lomustine |
| Pack Type | Box |
| Pack Size | 10 Capsules |
| Treatment | Brain Tumours |
Lomustine capsules, often prescribed under various brand names, including CCNU and Gleostine, are a vital component in the fight against brain tumors. As an alkylating agent, lomustine plays a crucial role in treating various forms of brain cancer, offering hope and improved outcomes for individuals facing these challenging diagnoses. In this article, we will explore the science behind lomustine capsules, their mechanisms of action, and their profound impact in the management of brain tumors.
Understanding Lomustine
Lomustine is an oral chemotherapy medication classified as an alkylating agent. It is used primarily in the treatment of brain tumors, including glioblastoma multiforme, anaplastic astrocytoma, and medulloblastoma, among others. Lomustine works by interfering with the growth and replication of cancer cells, thereby impeding the progression of brain tumors.
The Science of Lomustine
Alkylating Agent: Lomustine belongs to the alkylating agent class of chemotherapy drugs. These agents disrupt the DNA of cancer cells by adding alkyl groups to the DNA strands. This process interferes with DNA replication and ultimately leads to cell death.
Cell Cycle Arrest: Lomustine primarily targets rapidly dividing cells, which are a hallmark of cancer. By arresting the cell cycle and inhibiting DNA synthesis, it hampers the ability of cancer cells to multiply and spread.
Benefits of Lomustine Capsules
Brain Tumor Treatment: Lomustine is a cornerstone in the treatment of various brain tumors, helping to slow down their growth and progression.
Oral Administration: Lomustine is available in capsule form, making it convenient for patients to take as prescribed.
Improved Outcomes: Lomustine, when used as part of a comprehensive treatment plan, has been associated with improved survival rates and quality of life for individuals with brain tumors.
Combination Therapies: It is often used in combination with other treatments like surgery, radiation therapy, and other chemotherapy agents, enhancing its effectiveness.
Considerations
Lomustine is a potent chemotherapy medication and should only be used under the supervision of an oncologist or a healthcare provider with experience in cancer treatment. Due to its potential side effects and the need for careful monitoring, patients are typically closely observed during treatment.
Conclusion
Lomustine capsules are vital medications in the management of brain tumors, providing hope and improved outcomes for individuals facing these challenging diagnoses. As an alkylating agent, lomustine disrupts the DNA of cancer cells, inhibiting their replication and growth. If you or someone you know is dealing with a brain tumor diagnosis, consult with an oncologist to explore whether lomustine, as part of a comprehensive treatment plan, is a suitable option to manage the condition effectively. It has the potential to enhance the quality of life by impeding the growth of brain tumors and offering the possibility of improved outcomes.
₹ 234 / Box Get Latest Price
| Strength | 50 mg |
| Form | Tablet |
| Manufacturer | Hetero |
| Packaging Type | Box |
| Packaging Size | 1 X 10 Tablets |
| Brand | Bicatero |
| Prescription/Non prescription | Prescription |
| Shelf Life | 36 Months |
| Composition | Bicalutamide |
| Treatment | Treatment to metastatic prostate cancer (cancer that started in the prostate and has spread to |
₹ 129 / Strip Get Latest Price
| Strength | 200 mg |
| Packaging Size | 10 tablets |
| Brand | Acivir |
| Dosage Form | Tablet |
| Prescription | Prescription |
| Shelf Life | 24 months |
| Packaging Type | Strip |
₹ 400 / Box Get Latest Price
| Strength | 100 mg |
| Packaging Type | Box |
| Brand | Arpimune me |
| Shelf Life | 24 Months |
| Composition | Cyclosporine |
| Manufacturer | Pharmatech |
| Pack Size | 50 Capsules |
| Treatment | Used To Prevent Organ Rejection In Transplant Patients. |
Cyclosporine capsules are a medication used to treat a variety of medical conditions, primarily for their immunosuppressive properties. This prescription medication is available in capsule form and contains the active ingredient cyclosporine. Cyclosporine is a powerful immunosuppressant that helps suppress the body's immune response, making it useful in various medical situations. It is important to take this medication only as directed by your healthcare provider, as it can have potentially serious side effects and interactions.
Indications: Cyclosporine capsules are commonly prescribed for the following medical conditions:
Organ Transplantation: Cyclosporine is used to prevent rejection in organ transplant recipients. It helps to suppress the immune system's response to the foreign organ.
Autoimmune Diseases: Cyclosporine may be prescribed to individuals with autoimmune diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease to manage symptoms and reduce inflammation.
Severe Atopic Dermatitis: In certain cases, it is used to treat severe atopic dermatitis (eczema) when other treatment options have failed.
How it Works: Cyclosporine works by inhibiting the activity of certain immune cells that are responsible for initiating an immune response. This suppression of the immune system's function helps prevent rejection of transplanted organs and reduces the inflammatory response seen in autoimmune diseases.
Dosage and Administration: Cyclosporine capsules come in various strengths, and the appropriate dosage will depend on your specific medical condition, weight, and individual response to the medication. It's crucial to follow your healthcare provider's instructions precisely. Typically, the medication is taken orally, with or without food. Do not crush or chew the capsules; swallow them whole. If you miss a dose, consult your healthcare provider for guidance.
Possible Side Effects: Cyclosporine can cause a range of side effects, which may vary from person to person. Common side effects include:
Serious side effects are rare but can include kidney problems, high blood sugar, and an increased risk of infection. Regular monitoring by your healthcare provider is essential to manage and mitigate these potential issues.
Precautions: Before starting cyclosporine, inform your healthcare provider about any existing medical conditions, medications, or supplements you are taking. This medication can interact with various drugs and should be used cautiously in patients with certain conditions. Regular blood tests are typically required to monitor for potential side effects.
Conclusion: Cyclosporine capsules are a valuable medication for individuals requiring immunosuppression, such as transplant recipients and those with autoimmune diseases. It is crucial to follow your healthcare provider's guidance regarding dosage and monitoring to ensure the safe and effective use of this medication. Always consult your healthcare provider for personalized information and advice regarding your specific medical situation.
₹ 157 / Strip Get Latest Price
| Strength | 4 mg |
| Pack size | 10 tablets |
₹ 130 / Stripe Get Latest Price
| Dose/Strength | 250 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Manufacturer | Cipla |
| Shelf Life | 2 Years |
| Packaging Type | Box |
| Brand Type | Gefzest |
| Composition | Gefitinib |
| Treatment | Anti Cancer Tablet |
| Pack Size | 3 X 10 Tablets |
Gefitinib tablets, often marketed under brand names like Iressa, have emerged as a groundbreaking medication in the management of lung cancer. As a targeted therapy, gefitinib specifically targets the abnormal growth of cancer cells and has played a pivotal role in improving the prognosis and quality of life for individuals with certain types of lung cancer. In this article, we will explore the science behind gefitinib tablets, their mechanisms of action, and their remarkable impact on the treatment of lung cancer.
Understanding Gefitinib
Gefitinib is a medication that falls under the category of tyrosine kinase inhibitors (TKIs). It is primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly in cases where specific genetic mutations are present.
The Science of Gefitinib
Benefits of Gefitinib Tablets
Lung Cancer Treatment: Gefitinib has revolutionized the treatment of non-small cell lung cancer (NSCLC), especially in cases with EGFR mutations. It offers new hope to patients with advanced or metastatic lung cancer.
Targeted Therapy: Unlike traditional chemotherapy, gefitinib is a targeted therapy that specifically inhibits the growth of cancer cells, minimizing damage to healthy cells and reducing the side effects commonly associated with chemotherapy.
Oral Administration: Gefitinib is available in tablet form, making it convenient for patients to take as prescribed.
Improved Quality of Life: Gefitinib has been associated with prolonged survival and improved quality of life in many patients with NSCLC.
Treatment of Other Cancers: In addition to lung cancer, gefitinib is being explored for its potential in treating other types of cancer, expanding its impact in the field of oncology.
Considerations
Gefitinib is a prescription medication and should only be used under the guidance of a healthcare provider. Its use is typically limited to cases with specific EGFR mutations. Healthcare providers will determine eligibility, dosage, and treatment duration based on the individual's medical history and genetic profile.
Conclusion
Gefitinib tablets have transformed the landscape of lung cancer treatment, offering targeted therapy with remarkable results. By inhibiting the overactive EGFR protein in cancer cells, gefitinib helps control the growth and spread of non-small cell lung cancer. If you or a loved one is facing a diagnosis of NSCLC with EGFR mutations, consult with an oncologist to explore this innovative treatment option. Gefitinib has the potential to provide new hope, improved survival, and a better quality of life in the battle against lung cancer.
₹ 650 / Box Get Latest Price
| Strength | 0.5 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Brand | Advacan |
| Pack Type | Box |
| Pack Size | 3 X 10 Tablets |
| Manufacturer | Biocon |
| Composition | Everolimus |
| Treatment | Breast Cancer |
Everolimus tablets, often prescribed under brand names like Afinitor, have emerged as a groundbreaking medication in the realm of targeted therapy. As an mTOR inhibitor, everolimus plays a crucial role in the treatment of various medical conditions, from certain types of cancer to immunosuppression and even non-cancerous growths. In this article, we will delve into the science behind everolimus tablets, their mechanisms of action, and their diverse applications in the field of medicine.
Understanding Everolimus
Everolimus is a medication that falls under the category of mTOR (mammalian target of rapamycin) inhibitors. It is available in oral tablet form and is used to manage a range of medical conditions, both cancerous and non-cancerous.
The Science of Everolimus
mTOR Inhibition: Everolimus exerts its effects by inhibiting the mTOR pathway, a key regulator of cell growth and division. By blocking mTOR, everolimus interferes with the proliferation of cells, including cancer cells, immune cells, and non-cancerous cell growths.
Anti-Cancer Properties: In the treatment of certain cancers, everolimus works by arresting the growth and division of cancer cells. It is particularly effective in cases like advanced breast cancer, renal cell carcinoma, and pancreatic neuroendocrine tumors.
Immunosuppression: Everolimus has immunosuppressive properties, making it valuable in transplant medicine. It helps prevent the body from rejecting transplanted organs and tissues by suppressing the immune response.
Non-Cancerous Growth Management: Everolimus can also be used to manage non-cancerous growths, such as renal angiomyolipomas associated with tuberous sclerosis complex (TSC) or non-cancerous brain tumors (subependymal giant cell astrocytoma, or SEGA).
Benefits of Everolimus Tablets
Cancer Treatment: Everolimus is employed in the treatment of various cancers, offering new hope to patients with advanced or difficult-to-treat malignancies.
Immunosuppression: In the context of organ transplantation, everolimus is a valuable tool for preventing organ rejection and maintaining graft function.
Non-Cancerous Growth Control: Everolimus can help manage non-cancerous growths, such as those associated with tuberous sclerosis complex (TSC) or non-cancerous brain tumors.
Oral Administration: Everolimus is available in tablet form, making it easy for patients to take as prescribed.
Considerations
Everolimus is a potent medication with the potential for side effects, and its use requires close monitoring by healthcare providers. The specific regimen and dosage will depend on the medical condition being treated. Patients should discuss potential side effects, drug interactions, and the necessity for regular check-ups with their healthcare team.
Conclusion
Everolimus tablets represent a groundbreaking advancement in targeted therapy, offering solutions for a diverse range of medical conditions. By inhibiting the mTOR pathway, everolimus exerts its effects in cancer treatment, immunosuppression for transplant patients, and management of non-cancerous growths. If you or someone you know is facing a medical condition for which everolimus may be indicated, consult with a healthcare provider to explore the most suitable treatment options. Everolimus has the potential to improve outcomes, enhance the quality of life, and offer new possibilities in the management of a variety of conditions.
₹ 700 / Box Get Latest Price
| Strength | 0.25 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Brand | Advacan |
| Pack Type | Box |
| Pack Size | 3 X 10 Tablets |
| Manufacturer | Biocon |
| Composition | Everolimus |
| Treatment | Breast Cancer |
Everolimus tablets, often prescribed under brand names like Afinitor, have emerged as a groundbreaking medication in the realm of targeted therapy. As an mTOR inhibitor, everolimus plays a crucial role in the treatment of various medical conditions, from certain types of cancer to immunosuppression and even non-cancerous growths. In this article, we will delve into the science behind everolimus tablets, their mechanisms of action, and their diverse applications in the field of medicine.
Understanding Everolimus
Everolimus is a medication that falls under the category of mTOR (mammalian target of rapamycin) inhibitors. It is available in oral tablet form and is used to manage a range of medical conditions, both cancerous and non-cancerous.
The Science of Everolimus
mTOR Inhibition: Everolimus exerts its effects by inhibiting the mTOR pathway, a key regulator of cell growth and division. By blocking mTOR, everolimus interferes with the proliferation of cells, including cancer cells, immune cells, and non-cancerous cell growths.
Anti-Cancer Properties: In the treatment of certain cancers, everolimus works by arresting the growth and division of cancer cells. It is particularly effective in cases like advanced breast cancer, renal cell carcinoma, and pancreatic neuroendocrine tumors.
Immunosuppression: Everolimus has immunosuppressive properties, making it valuable in transplant medicine. It helps prevent the body from rejecting transplanted organs and tissues by suppressing the immune response.
Non-Cancerous Growth Management: Everolimus can also be used to manage non-cancerous growths, such as renal angiomyolipomas associated with tuberous sclerosis complex (TSC) or non-cancerous brain tumors (subependymal giant cell astrocytoma, or SEGA).
Benefits of Everolimus Tablets
Cancer Treatment: Everolimus is employed in the treatment of various cancers, offering new hope to patients with advanced or difficult-to-treat malignancies.
Immunosuppression: In the context of organ transplantation, everolimus is a valuable tool for preventing organ rejection and maintaining graft function.
Non-Cancerous Growth Control: Everolimus can help manage non-cancerous growths, such as those associated with tuberous sclerosis complex (TSC) or non-cancerous brain tumors.
Oral Administration: Everolimus is available in tablet form, making it easy for patients to take as prescribed.
Considerations
Everolimus is a potent medication with the potential for side effects, and its use requires close monitoring by healthcare providers. The specific regimen and dosage will depend on the medical condition being treated. Patients should discuss potential side effects, drug interactions, and the necessity for regular check-ups with their healthcare team.
Conclusion
Everolimus tablets represent a groundbreaking advancement in targeted therapy, offering solutions for a diverse range of medical conditions. By inhibiting the mTOR pathway, everolimus exerts its effects in cancer treatment, immunosuppression for transplant patients, and management of non-cancerous growths. If you or someone you know is facing a medical condition for which everolimus may be indicated, consult with a healthcare provider to explore the most suitable treatment options. Everolimus has the potential to improve outcomes, enhance the quality of life, and offer new possibilities in the management of a variety of conditions.
₹ 840 / Box Get Latest Price
| Dose/Strength | 90 mg |
| Composition | Ticagrelor |
| Packaging Type | Box |
| Brand | Brilinta |
| Manufactured By | Astra Zeneca |
| Shelf Life | 2 years |
| Treatment | It Makes Your Blood Flow Through Your Veins More Easily. |
| Pack Size | 1 X 14 Tablets |
₹ 684 / Box Get Latest Price
| Dose/Strength | 60 mg |
| Composition | Ticagrelor |
| Packaging Type | Box |
| Brand | Brilcure |
| Manufactured By | Indizen Pharmaceutical |
| Shelf Life | 2 years |
| Pack Size | 10 x 14 Tablets |
| Treatment | It Makes Your Blood Flow Through Your Veins More Easily. |
₹ 184 / Box Get Latest Price
| Dose/Strength | 25 mg |
| Form | Tablet |
| Packaging Type | Box |
| Storage Condition | Below 30 Degree C |
| Prescription/Non prescription | Prescription |
| Shelf Life | 2 Years |
| Treatment | Treatment Of Advanced Breast Cancer |
| Pack Size | 3 X 10 Tablets |
| Composition | Exemestane |
| Brand | Xmalon |
₹ 284 / Box Get Latest Price
| Strength | 160 mg |
| Form | Tablet |
| Pack Size | 1*10 Tablet |
| Pack Type | Box |
| Storage Condition | Below 30 Degree C |
| Prescription/Non prescription | Prescription |
| Brand Name | Megstral |
| Composition | Megestrol |
| Treatment | Used To Treat Breast And Endometrial Cancer. |
₹ 680 / Box Get Latest Price
| Strength | 500 mg |
| Form | Tablet |
| Pack Size | 1*10 Tablets |
| Pack Type | Box |
| Brand Name | Capiibine |
| Prescription/Non prescription | Prescription |
| Manufacturer | Dr.Reddy's |
| Shelf Life | 24 Months |
| Treatment | To Treat Certain Types Of Cancer |
₹ 284 / Box Get Latest Price
| Dose/Strength | 400 mg |
| Form | Tablet |
| Packaging Type | Box |
| Prescription/Non prescription | Prescription |
| Shelf Life | 24 Months |
| Treatment | Treat Chronic Myeloid Leukaemia |
| Brand Name | Ontinib |
| Composition | Imatinib |
| Manufacturer | Oncozest |
| Pack Size | 3 X 10 Tablets |
₹ 500 / Box Get Latest Price
| Strength | 500 mg |
| Packaging Type | Box |
| Packaging Size | 10 x 10 Capsules |
| Prescription/Non prescription | Prescription |
| Brand | Myelostat |
| Manufactured By | Zydus |
| Shelf Life | 24 Months |
| Composition | Hydroxyurea |
| Treatment | Used To Treat Cancer Of The White Blood Cells Called Chronic Myeloid Leukemia (CML) |
₹ 630 / Box Get Latest Price
| Strength | 500 mg |
| Packaging Type | Box |
| Brand | Cellmune |
| Manufacturer | Cipla |
| Shelf life | 36 Months |
| Prescription / Non prescription | Prescription |
| Pack Size | 2 X 10 Tablets |
| Composition | Mycophenolate Mofetil |
| Treatment | To Prevent Organ Transplant Rejection |
₹ 7080 / Box Get Latest Price
| Strength | 5 mg |
| Prescription/Non prescription | Prescription |
| Packaging Size | 10 Capsules |
| Brand | Lenangio |
| Manfacturer | Dr.Reddy's |
| Pack Type | Box |
| Composition | Lenalidomide |
| Treatment | Used To Treat Multiple Myeloma, Myelodysplastic Syndromes, Mantle Cell Lymphoma |
₹ 3619 / Box Get Latest Price
| Dose/Strength | 250 mg |
| Form | Tablet |
| Brand | Geftib |
| Prescription/Non prescription | Prescription |
| Manufacturer | Glenmark |
| Shelf Life | 24 Months |
| Packaging Type | Box |
| Treatment | Used To Treat Non-Small Cell Lung Cancer |
| Composition | Gefitinib |
| Pack Size | 30 Tablets |
Geffy 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.
Uses of Geffy 250mg TabletGeffy 250mg Tablet is used to treat
Therapeutic Effects of Geffy 250mg Tablet
It is an anilinoquinazoline derivative which interacts with a kinase inhibitor that inhibits an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.
Interaction of Geffy 250mg Tablet with other drugsInform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Geffy 250mg Tablet and reduce effectiveness by causing undesirable side effects.
More Information about Geffy 250mg Tablet₹ 286 / Box Get Latest Price
| Strength | 1 mg |
| Form | Tablet |
| Packaging Type | Box |
| Prescription/Non prescription | Prescription |
| Brand | Anastronat |
| Manufactured By | Natco |
| Shelf Life | 24 Months |
| Composition | Anastrozole |
| Packaging Size | 30 Tablets |
| Treatment | Treat Breast Cancer In women |
₹ 88 / Vial Get Latest Price
| Packaging Type | Vial |
| Pack Size | 5 ml |
| Brand Name | Biotrexate |
| Manufacturer | Zydus |
| Composition | Methotrexate |
| Treatment | Treat Breast Cancer |
| Strength | 500 mg |
₹ 84 / Box Get Latest Price
| Strength | 160 mg |
| Form | Tablet |
| Pack Type | Box |
| Storage Condition | Below 30 Degree C |
| Prescription/Non prescription | Prescription |
| Brand Name | Megte |
| Manufacturer | Oncozest |
| Packaging Size | 3 x 10 Tablets |
| Composition | Megestrol Acetate |
| Treatment | Breast Cancer |
₹ 3930 / Box Get Latest Price
| Strength | 50 mg/vial |
| Packaging Type | Vial |
| Packaging Size | Single Vial dose |
| Presciption/Non Prescription | Presciption |
| Brand | Alkacel |
| Manufacturer | Celon Labs |
| Composition | Melphalan |
| Treatment | To Treat Multiple Myeloma |
₹ 206 / Strip Get Latest Price
| Strength | 1 mg |
| Brand | Anastronat |
| Tablets per Pack | 14 Tablets |
| Pack Type | Strip |
₹ 430 / Box Get Latest Price
| Strength | 400 mg |
| Packaging Size | 25 tablets |
| Brand | Acivir |
| Dosage Form | Tablet |
| Shelf Life | 24 months |
| Packaging Type | Strip |
| Country of Origin | India |
₹ 500 / Box Get Latest Price
| Strength | 100 mg |
| Prescription/Non prescription | Prescription |
| Manufacturer | Cipla |
| Shelf Life | 2 Years |
| Storage Instruction | Under 25 Degree C |
| Composition | Temozolomide |
| Treatment | Used To Treat Specific Types Of Brain Cancer |
| Brand Name | Temoside |
| Pack Size | 5 Capsules |
Temozolomide, often prescribed under brand names like Temodar, has revolutionized the treatment of brain tumors. As an oral chemotherapy medication, temozolomide is particularly effective in managing malignant brain tumors, offering hope and improved outcomes for individuals facing these challenging diagnoses. In this article, we will explore the science behind temozolomide, its mechanisms of action, and its profound impact on the treatment of brain tumors.
Understanding Temozolomide
Temozolomide is an alkylating agent and an oral chemotherapy medication. It is primarily used in the treatment of malignant brain tumors, such as glioblastoma multiforme (GBM) and anaplastic astrocytoma.
The Science of Temozolomide
Alkylating Agent: Temozolomide works by adding a chemical group (alkyl group) to the DNA of rapidly dividing cells, including cancer cells. This process interferes with DNA replication and ultimately leads to cell death.
Cell Cycle Disruption: Temozolomide primarily targets rapidly dividing cells, which are characteristic of cancer. By disrupting the cell cycle and inhibiting DNA synthesis, it hampers the ability of cancer cells to multiply and spread.
Benefits of Temozolomide
Effective Brain Tumor Treatment: Temozolomide is highly effective in the treatment of malignant brain tumors, offering new hope to patients with these challenging diagnoses.
Oral Administration: Temozolomide is available in tablet form, making it convenient for patients to take as prescribed.
Improved Outcomes: When used as part of a comprehensive treatment plan, temozolomide has been associated with improved survival rates and quality of life for individuals with malignant brain tumors.
Combination Therapies: It is often used in combination with other treatments, such as radiation therapy and other chemotherapy agents, enhancing its effectiveness.
Considerations
Temozolomide is a potent chemotherapy medication and should only be used under the supervision of an oncologist or healthcare provider experienced in cancer treatment. Patients may experience side effects, and the specific regimen and dosage will depend on the type and stage of the brain tumor being treated. Regular monitoring and check-ups are essential during treatment.
Conclusion
Temozolomide has transformed the landscape of brain tumor treatment, offering precision therapy with significant results. By disrupting the DNA of cancer cells, temozolomide helps control the growth and spread of malignant brain tumors. If you or a loved one is facing a diagnosis of a malignant brain tumor, consult with an oncologist to explore this innovative treatment option. Temozolomide has the potential to provide new hope, improved survival, and a better quality of life in the battle against these challenging conditions.
₹ 4220 / Box Get Latest Price
| Strength | 30 mg |
| Form | Tablet |
| Manufacturer | Intas Pharmaceuticals |
| Prescription/Non prescription | Prescription |
| Shelf life | 24 Months |
| Brand | Afanat |
| Packaging Size | 28 Tablets |
| Composition | Afatinib |
| Pack Type | Box |
| Treatment | Used To Treat A Certain Type Of Lung Cancer |
₹ 20000 / Box Get Latest Price
| Strength | 40 mg |
| Form | Capsules |
| Manufacturer | BD |
| Storage Condition | Below 30 Degree C |
| Prescription/Non prescription | Prescription |
| Brand | Bdenza |
| Composition | Enzalutamide |
| Treatment | Treatment Of Cancer Of The Prostate Gland |
| Pack Size | 4 X 28 Capsules |
| Pack Type | Box |
₹ 33100 / Box Get Latest Price
| Strength | 250 mg |
| Packaging Type | Box |
| Manufactured By | Cadila |
| Brand | Fuvestrol |
| Composition | Fulvestrant |
| Pack Size | 5ml |
| Treatment | Advanced Breast Cancer |
₹ 8700 / Box Get Latest Price
| Strength | 10 mg |
| Pack Type | Box |
| Storage Condition | Below 30 Degree C |
| Prescription/Non prescription | Prescription |
| Packaging Size | 100 Softgel Capsules |
| Manufacturer | Bryogen |
| Brand | CA Atra |
| Treatment | Treat A Type Of Blood Problem Called Acute Promyelocytic Leukaemia |
| Composition | Retinoic Acid |
₹ 2790 / Box Get Latest Price
| Strength | 200 mg |
| Prescription/Non prescription | Prescription |
| Composition | Nilotinib |
| Pack Type | Box |
| Pack Size | 3 X 10 Capsules |
| Manufacturer | Natco |
| Brand | Knilonat |
| Treatment | Treatment Of Blood Cancer |
₹ 30000 / Vial Get Latest Price
| Strength | 120 mg |
| Pack Size | 3 ml |
| Pack Type | Vial |
| Brand Name | Vivdoc |
| Manufacturer | Alish |
| Composition | Docetaxel |
| Treatment | Treatment Of Breast Cancer |
₹ 247 / Strip Get Latest Price
₹ 438 / Box Get Latest Price
₹ 433 / Box Get Latest Price
Amitrajan Sharma (CEO)
Savvymeds Healthcare Private Limited
Capanna-8,Koradi, Road, Ramnath City, Nagpur - 441111, Maharashtra, India